Knorex Debuts at $4, IPO Set at $4 per Share
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 29 2025
0mins
Should l Buy KNRX?
Initial Public Offering Details: Knorex has priced its IPO at $4.00 per share for a total of 3 million Class A ordinary shares, all offered by the company.
Trading Information: The Class A ordinary shares are listed on the NYSE American under the ticker symbol "KNRX".
Management of the Offering: R. F. Lafferty & Co. is the lead book-running manager, while Craft Capital Management serves as the co-manager for the IPO.
Company Background: Knorex specializes in AI-driven digital advertising products and solutions.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy KNRX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on KNRX
About KNRX
Knorex Ltd. is a Business to Business (B2B) technology company. The Company is specialized in providing programmatic advertising products and solutions to marketers to streamline and automate their advertising and marketing workflows. Its flagship product, Knorex XPO, is a self-service enterprise-grade cloud platform with a comprehensive suite of advertising management and execution (AMX) applications.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Significant Price Surge: Vanda Pharmaceuticals' shares jumped 33% in pre-market trading to $7.65, indicating strong market confidence in its future performance, which may attract more investor interest.
- Positive Market Reaction: This price surge reflects optimistic expectations from investors regarding Vanda's potential growth opportunities, potentially facilitating further development in the biopharmaceutical sector.
- Increased Trading Activity: With the notable price increase, Vanda's trading volume is likely to rise, providing the company with enhanced liquidity to support its R&D and market expansion plans.
- Improved Investor Sentiment: The rise in Vanda's stock price may enhance overall investor sentiment, particularly in the biopharmaceutical industry, further boosting the performance of related stocks.
See More
- Earnings Beat: Comfort Systems reported earnings of $9.37 per share, surpassing the analyst consensus estimate of $6.75, indicating a significant improvement in profitability and boosting investor confidence.
- Sales Growth: The company achieved quarterly sales of $2.646 billion, exceeding the analyst consensus estimate of $2.337 billion, reflecting strong market demand and driving overall performance.
- Positive Stock Reaction: Comfort Systems shares jumped 4.6% to $1,436.25 in pre-market trading, indicating a favorable market response to the earnings report, which may attract more investor interest.
- Optimistic Market Outlook: The strong earnings data not only enhances the company's short-term stock price but also lays the groundwork for future growth, increasing market attractiveness for long-term investments in Comfort Systems.
See More
- Stock Surge: Knorex Ltd. (KNRX) experienced a remarkable stock increase of over 170% on Thursday following the launch of its latest AI-ready ads API, indicating strong market enthusiasm and investor confidence in the company's growth potential.
- Technological Innovation: The API is specifically designed for the agentic AI era, automating workflows across Meta, Google, LinkedIn, and TikTok ads, marking a significant breakthrough in ad tech that enhances Knorex's competitive position in the market.
- Surge in Demand: With a remarkably low float of approximately 17.8 million shares, primarily held by insiders and early investors, the news triggered a tidal wave of demand for the limited supply of shares, resulting in trading volume skyrocketing to over 44 million shares by midday, far exceeding the typical daily average.
- Significant Price Volatility: After hitting an all-time low of 75 cents just last week, KNRX's stock reached a session high of $3.45 on Thursday before consolidating around the $2.30 mark, reflecting heightened market interest and active speculative trading around the stock.
See More
- Market Performance: U.S. stocks opened lower this morning, with the Dow Jones index dropping over 250 points, a decline of 0.54% to 49,394.62, indicating weakened market sentiment that could impact investor confidence.
- Jobless Claims Data: Initial jobless claims in the U.S. fell by 23,000 to 206,000, below market expectations of 225,000, suggesting a resilient labor market that may positively influence economic recovery.
- Energy Stocks Rise: Energy shares gained 1.5% on Thursday, reflecting optimistic expectations for energy demand, which could present profit growth opportunities for related companies.
- Commodity Market Dynamics: Oil prices increased by 2.1% to $66.55, while gold rose 0.1% to $5,012.00, indicating heightened demand for safe-haven assets, which may influence future investment strategies.
See More
- Market Potential: Global digital advertising spend is projected to exceed $740 billion by 2026, positioning KNOREX's AI-driven advertising solutions to capitalize on this trend and enhance ad effectiveness for enterprises in a competitive landscape.
- Strategic Partnerships: KNOREX has successfully deployed its Ads API with three strategic partners, including two in the U.S. and one in Southeast Asia, marking the initial commercial rollout of the technology and expected to drive future market expansion.
- Technological Innovation: The KNOREX Ads API's compatibility with the Amazon Ads MCP Server allows customers to build AI agents using natural language prompts, streamlining ad management processes, reducing maintenance costs, and improving efficiency.
- Industry Transformation Opportunity: By launching an open, AI-ready Ads API, KNOREX not only enhances its platform scalability but also lays the groundwork for automation transformation in the advertising industry, further solidifying its competitive position in the market.
See More
- Executive Appointment: KNOREX has appointed Ning (Michael) Sun as Chief Financial Officer, effective January 22, 2026, aiming to strengthen its executive leadership team to support future growth.
- Capital Markets Expertise: During his tenure at KNOREX as head of capital markets, Sun led capital markets planning, investor engagement, and pre-IPO initiatives, showcasing his extensive experience in capital operations.
- Previous Roles: Before joining KNOREX, Sun held senior positions at U.S.-listed companies Jiayin Group and Fang Holdings, including Vice President of capital markets at Jiayin Group and Director of investor relations at Fang Holdings, providing him with a solid industry background.
- Strategic Importance: Sun's appointment is viewed as a crucial step for KNOREX in building internal infrastructure to support its next phase of growth as a public company, reflecting the company's commitment to future development.
See More






